Today, shares of Helix Biopharm opened at $0.20 and closed at $0.20. It traded at a low of $0.20 to a high of $0.20.

Share prices advanced 8.11% from the previous day's close of $0.18.

During the day across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Helix Biopharm traded under HBP on the Toronto Stock Exchange (TSX).

A total of 1,011 shares was traded during the last trading day, with total trades of 2. On average, Helix Biopharm has traded 5,681 shares over 5 days and 15,873 year-to-date.

The TSX market on the whole today saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, HBP.TO has traded as high as $0.26 (October 11,2023) and low as $0.15 (October 19,2023). Moreover, in the last 12 months, Helix Biopharm's shares have shrunken -4.76 percent, while they have decreased -4.76% year-to-date.

Following today's trading, Helix Biopharm has a market capitalization of $45.89 million on a float of 229,441 shares outstanding. Its annual EPS is $-0.03.

Helix Biopharm is a None company headquartered in Toronto, CAN.

Helix Biopharm is holding an average recommendation of "Strong Buy" from 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..